| 摘要 |
5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy] benzyl]thiazolidine-2, 4-dione, heterochloride dihydrate characterized in that: (i) provides an infrared spectrum containing peaks at 3392, 2739, 1751, 1325 and 713 cm-1; and/or provides an X-ray powder diffraction (XRPD) pattern containing peaks at 9.1, 12.0, 15.7, 16.3 and 19.8 ..2 theta; a process for preparing such a compound, a pharmaceutical composition containing such a compound and the use of such a compound in medicine. 12 claims, 2 figures |
